Interferon-gamma 1b-induced gene expression alters neutrophil function in patients with chronic granulomatous disease
Open Access
- 8 September 2025
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (9) , e0331657
Abstract
Interferon-gamma (IFN-γ) decreases infections in chronic granulomatous disease (CGD) with variably incomplete restoration of the fundamental CGD defect, converting oxygen to microbicidal oxidants during phagocytosis. We sought to understand other IFN-γ effects that could contribute to protection of CGD patients. We measured neutrophil function, gene expression, and biochemical parameters in nine CGD patients off IFN-γ and 10–12 hours after the first (1st) and fourth (4th) IFN-γ injection. Non-directed motility and bactericidal activity increased after IFN-γ administration; ingestion remained unchanged. Stimulated release of superoxide anion (O2-) was minimally changed. Treatment decreased expression of 483 genes and increased 386. Expression of eleven genes associated with neutrophil activity was upregulated. Genes not routinely associated with neutrophil function also demonstrated increased expression, including MHCI & II proteins, guanylate-binding proteins, and an enzyme synthesizing a nitric-oxide (NO) synthetase cofactor. CD11b expression, F-actin assembly, and CD 274 antigen were increased after treatment as was NO in neutrophil lysates. Formation of neutrophil extracellular traps after ingestion of staphylococci was increased off IFN-γ compared with controls but moved toward normal after IFN-γ administration. IFN-γ protects against infection in CGD by several mechanisms that could potentially support others with compromised host defense. Trial registration: ClinicalTrials.gov NCT03548818Keywords
Funding Information
- Horizon Therapeutics
- Stacy True Memorial Trust Fund
- Marranzino and Morgan families
- NIH/NCATS (UL1 TR002535)
This publication has 50 references indexed in Scilit:
- Chronic Granulomatous Disease: an Updated Experience, with Emphasis on Newly Recognized FeaturesJournal of Clinical Immunology, 2022
- Primary Immunodeficiency and Other Diseases With Immune Dysregulation2018
- Measurement of NET formation in vitro and in vivo by flow cytometryCytometry Part A, 2017
- Phox activity of differentiated PLB‐985 cells is enhanced, in an agonist specific manner, by the PLA2 activity of Prdx6‐PLA2European Journal of Immunology, 2012
- Peroxiredoxin 6 translocates to the plasma membrane during neutrophil activation and is required for optimal NADPH oxidase activityBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2012
- Polymorphonuclear neutrophils pulsed with synthetic peptides efficiently activate memory cytotoxic T lymphocytesJournal of Leukocyte Biology, 1996
- Poly's lament: the neglected role of the polymorphonuclear neutrophil in the afferent limb of the immune responseImmunology Today, 1992
- Flow cytometric assay for the measurement of serum opsonins to Neisseria meningitidis serogroup B, serotype 15Journal of Immunological Methods, 1989
- Studies of phagocytosis in chronic granulomatous diseaseInflammation, 1987
- Differentiation between attached and ingested immune complexes by a fluorescence quenching cytofluorometric assayJournal of Immunological Methods, 1983